Hereditary Cancer
Patient Central

Why Myriad?

Up to 1 in 6¹ men with prostate cancer have a genetic mutation that may have caused their cancer. Germline hereditary cancer testing is the only way to identify this risk and Myriad offers a suite of tests to provide you with personalized information to create a customized cancer treatment plan.

What is Germline Testing?

Germline testing is a genetic test conducted on blood or saliva to determine if your prostate cancer was caused by an inherited genetic mutation. Every man with prostate cancer deserves to know his germline mutation status and recent changes now make it possible and easier than ever.

Did You Know

Men with localized prostate cancer and BRCA mutations are²

6× more likely
to die from prostate cancer
within 5 years

4× more likely
to develop prostate cancer metastasis within 5 years

Live ~7 years less

Ready to Learn More

Knowing your germline status early in your treatment journey not only helps guide treatment and management decisions, it could also qualify you for life-sustaining therapies should you progress to metastasis.

Why Myriad?

Ed Hoppe received a prostate cancer diagnosis in 2017. After his diagnosis, he also received germline testing from Myriad Genetics and learned about a mutation in his BRCA1 gene, classifying his cancer as hereditary.

Watch as Ed’s daughters share their own genetic testing stories.

What is Hereditary Cancer?

Approximately 5%-10% of all cancers are hereditary.

In some families, there tends to be more cancer, or more related kinds of cancer than you would normally expect to see in the general population.

Hereditary cancer occurs when a gene mutation is passed down from parent to child. People with hereditary cancer mutations in their family are more likely to have relatives with the same type or other related types of cancer.

They are also at higher risk for developing more than one cancer and their cancer often occurs at an earlier age.


Myriad Germline testing provides you with YOUR personalized hereditary cancer risk.

To see if you should consider Myriad Germline testing:

Prostate Cancer is a Hereditary Cancer

Did you know up to 1 in 6¹ men with prostate cancer have a genetic mutation that may have caused their cancer and that this inherited mutation could have been passed down from either your mother’s or father’s side of the family.

However, family history of prostate cancer is only one factor to consider with hereditary cancers. Did your mother have breast or ovarian cancer? Did your uncle have pancreatic or colon cancer? The same mutation responsible for their cancers could also be the reason behind your prostate cancer.

Therefore, understanding your family’s complete cancer history is crucial; especially since early detection is key with hereditary cancers.

If you have a gene mutation, your sons, daughters, and siblings all have a 50% chance of having the same mutation, which means they could be at risk for getting cancer or getting a worse form of cancer.

If you meet any of the following red flags, you should consider pursuing genetic testing.

Does Cancer Run in Your Family?

Download the attached screener to take to your next doctor appointment.

Which Test is Right for Me?

Myriad offers personalized testing options so that you can better understand your individual cancer risk and customize your treatment journey.

Hereditary Cancer Panel Testing:

Myriad myRisk® test is a 35-gene cancer panel that will provide patients with prostate cancer comprehensive information about your unique cancer. Using industry leading accuracy, unmatched turnaround time, and a lifetime commitment to patients, myRisk is an essential part of prostate cancer evaluations.

BRCA Testing – To Help Determine which Patients may be Appropriate for PARP Inhibitor Therapy

CDx can help determine if you might be an appropriate candidate for PARP inhibitor therapy by identifying if you have a germline BRCA 1/2 mutation. The test was designed and FDA approved to provide BRCA 1/2 results quickly and accurately.

Benefits of Myriad Germline Testing

Knowing your hereditary cancer status is critical when it comes to making treatment decisions and understanding your true risk.

Benefits for Individuals

• Improved risk stratification and surveillance

• Qualify for targeted therapies

• Qualify for clinical research trials

YOU deserve a better answer

Benefits for Families

• Increased surveillance and screening

• Preventative surgery and medications to reduce risk

• Prevent future cancers

FAMILIES deserve a better answer

Insurance Coverage

97% of private insurances have coverage for testing

3 out of 4 patients pay $0

Myriad will work with you toward your complete satisfaction if you encounter any financial hardship.

How it Works

Testing is quick and easy and can be done directly in the doctor’s office by collecting a small amount of blood or saliva.

Blood or saliva sample is collected and sent to Myriad

Sample is analyzed using state-of-the-art technology and reviewed by a team of genetic specialists.

Results are mailed directly to your healthcare provider in approximately 2 weeks

Submit the form below to receive your Testing Kit

*You can request your own genetics test kit, but for the test to be covered under insurance, it needs to be ordered by a health care provider.

Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and committment to protecting your privacy, please review our privacy policy.


At Myriad, we understand the importance of your privacy and respect every patient’s right to protected health information.


  1. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines Nicolosi et al. JAMA Oncol 2019
  2. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer. Castro et al. J Clin Oncol 31 (2013)